CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 16  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0611
LYS 10.0279
GLU 20.0287
LEU 30.0202
ARG 40.0102
CYS 50.0168
GLN 60.0150
CYS 70.0177
ILE 80.0100
LYS 90.0075
THR 100.0113
TYR 110.0161
SER 120.0426
LYS 130.0467
PRO 140.0178
PHE 150.0152
HIS 160.0091
PRO 170.0023
LYS 180.0057
PHE 190.0060
ILE 200.0069
LYS 210.0181
GLU 220.0145
LEU 230.0053
ARG 240.0040
VAL 250.0091
ILE 260.0164
GLU 270.0355
SER 280.0328
GLY 290.0247
PRO 300.0611
HIS 310.0134
CYS 320.0092
ALA 330.0297
ASN 340.0340
THR 350.0312
GLU 360.0172
ILE 370.0060
ILE 380.0055
VAL 390.0063
LYS 400.0163
LEU 410.0165
SER 420.0268
ASP 430.0389
GLY 440.0361
ARG 450.0321
GLU 460.0197
LEU 470.0108
CYS 480.0096
LEU 490.0045
ASP 500.0048
PRO 510.0047
LYS 520.0112
GLU 530.0142
ASN 540.0150
TRP 550.0087
VAL 560.0060
GLN 570.0101
ARG 580.0111
VAL 590.0065
VAL 600.0048
GLU 610.0077
LYS 620.0083
PHE 630.0048
LEU 640.0043
LYS 650.0120
ARG 660.0066
ALA 670.0069
GLU 680.0193
ASN 690.0248

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.